mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
0.02 |
0.5 |
mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
Bosutinib |
FIMM |
pan-cancer |
AAC |
0.25 |
0.5 |
mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.024 |
0.5 |